Daniel P. Finke - Jun 7, 2021 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP/Pres, Health Care Benefits
Signature
/s/ Daniel P. Finke
Stock symbol
CVS
Transactions as of
Jun 7, 2021
Transactions value $
-$1,504,220
Form type
4
Date filed
6/8/2021, 04:48 PM
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Options Exercise $1.75M +32.3K +113.07% $54.19 60.9K Jun 7, 2021 Direct
transaction CVS Common Stock Sale -$3.26M -37.6K -61.73% $86.60 23.3K Jun 7, 2021 Direct F1, F2
holding CVS Common Stock (pep) 3.04K Jun 7, 2021 Direct
holding CVS Common Stock (restricted) 25.7K Jun 7, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Options Exercise $0 -32.3K -50% $0.00 32.3K Jun 7, 2021 Common Stock 32.3K $54.19 Direct F3
holding CVS Stock Option 54.3K Jun 7, 2021 Common Stock 54.3K $58.34 Direct F4
holding CVS Stock Option 82.1K Jun 7, 2021 Common Stock 82.1K $74.30 Direct F5
holding CVS Stock Option 28.6K Jun 7, 2021 Common Stock 28.6K $52.37 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan.
F2 Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging from $86.52 and $86.71 per share.
F3 Option became exercisable in four equal annual installments, beginning on 4/1/2020.
F4 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F5 Option becomes exercisable in four equal installments, commencing 4/1/2022.
F6 Option becomes exercisable in three equal installments, commencing 5/31/2022.